These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 224851)

  • 21. Coronavirus-associated antibodies in nasopharyngeal carcinoma and infectious mononucleosis.
    Arnold W; Klein M; Wang JB; Schmidt WA; Trampisch HJ
    Arch Otorhinolaryngol; 1981; 232(2):165-77. PubMed ID: 6268032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of Epstein-Barr virus nuclear antigen in nasopharyngeal carcinoma biopsies and their derived cultures.
    de-Thé G; Ablashi DV; Favre MC; Mourali N; Ellouz R
    Bibl Haematol; 1975; (40):101-3. PubMed ID: 169807
    [No Abstract]   [Full Text] [Related]  

  • 23. The capsid antigen of Epstein-Barr virus in nasopharyngeal carcinomas: comparison of serum antibody titre, cellular antigen content and histopathology.
    Falser N
    Arch Otorhinolaryngol; 1984; 239(1):15-23. PubMed ID: 6318710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epstein-Barr virus and human malignancy.
    Ziegler JL; Magrath IT; Gerber P; Levine PH
    Ann Intern Med; 1977 Mar; 86(3):323-36. PubMed ID: 190930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis B core and surface antigens in liver tissue. Light and electron microscopic localization by the peroxidase-labeled antibody method.
    Yamada G; Nakane PK
    Lab Invest; 1977 Jun; 36(6):649-59. PubMed ID: 325296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultrastructural and immunohistochemical findings in oral hairy leukoplakia.
    Zhang XL; Langford A; Becker J; Rabanus JP; Pohle HD; Reichart P; Gelderblom H
    Virchows Arch A Pathol Anat Histopathol; 1988; 412(6):533-42. PubMed ID: 2834863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Studies on the relationship between clinical course and antibody titer to Epstein-Barr virus in nasopharyngeal carcinoma (author's transl)].
    Inuyama Y; Saito S; Ozu R; Horiuchi M; Asaoka K
    Nihon Jibiinkoka Gakkai Kaiho; 1975 Dec; 78(12):1237-43. PubMed ID: 176338
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of IgA serum antibodies to EB virus VCA in patients having survived nasopharyngeal cancer for over 15 years (author's transl)].
    Tang ZH
    Zhonghua Yi Xue Za Zhi; 1982 Mar; 62(3):167-9. PubMed ID: 6286059
    [No Abstract]   [Full Text] [Related]  

  • 29. [Study on the relationship between the serum IgA antibody titres to EB VCA and the pathological changes in untreated nasopharyngeal carcinoma (NPC) patients].
    Li JT; Zong YS
    Zhonghua Bing Li Xue Za Zhi; 1986 Jun; 15(2):122-5. PubMed ID: 3022953
    [No Abstract]   [Full Text] [Related]  

  • 30. [The diagnosis of nasopharyngeal carcinoma (author's transl)].
    Arnold W; Nakazima A; Wang YB; Vosteen KH; Brunner H; Göbel U
    HNO; 1980 Aug; 28(8):247-60. PubMed ID: 6254933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasopharyngeal carcinoma in Japan--clinical evaluation of EBV serology and EBV-associated nuclear antigens test.
    Takimoto T; Furukawa M; Morishita K; Umeda R; Hatano M
    Auris Nasus Larynx; 1982; 9(3):151-63. PubMed ID: 6301414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Diagnostic evaluation of anti-EBV(VCA and EA) antibody titration in patients with nasopharyngeal carcinoma (author's transl)].
    Takimoto T
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Mar; 82(3):255-62. PubMed ID: 228017
    [No Abstract]   [Full Text] [Related]  

  • 33. [Demonstration of Epstein-Barr virus genome in european Burkitt lymphoma (author's transl)].
    Wutzler P; Sprössig M; Hirsch J; Brichaćek B; Vonka V; Schindler E; Wutke K; Rüdiger KD; Wöckel W
    Dtsch Med Wochenschr; 1980 Jul; 105(27):961-6. PubMed ID: 6250783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Epstein-Barr virus--a clinically relevant feature of nasopharyngeal carcinoma? (author's transl)].
    Wilmes E; Wolf H; Deinhardt F; Naumann HH
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):4-6. PubMed ID: 6261051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The rescue of Epstein--Barr virus from primary cultured cells of nasopharyngeal carcinoma.
    Takada M; Murata M; Takei M; Nakagawa S; Okumura H; Kawamura A
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):177-89. PubMed ID: 228891
    [No Abstract]   [Full Text] [Related]  

  • 36. [Investigations of nasopharyngeal carcinomas with regard to the viral etiology].
    Arnold W; Huth F
    Arch Otorhinolaryngol; 1979; 223(2):212-214. PubMed ID: 32214605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EB viral genomes in epithelial nasopharyngeal carcinoma cells.
    Wolf H; zur Hausen H; Becker V
    Nat New Biol; 1973 Aug; 244(138):245-7. PubMed ID: 4353684
    [No Abstract]   [Full Text] [Related]  

  • 38. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.
    Huang DP; Ho JH; Henle W; Henle G
    Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471
    [No Abstract]   [Full Text] [Related]  

  • 39. Epithelial characteristics of tumor cells in nasophasyngeal carcinoma.
    de-Thé G; Vuillaume M; Giovanella BC; Klein G
    J Natl Cancer Inst; 1976 Nov; 57(5):1101-5. PubMed ID: 187791
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.
    Aya T; Osato T
    Int J Cancer; 1974 Sep; 14(3):341-7. PubMed ID: 4376517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.